Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Systems and methods for the treatment of hemoglobinopathies

Systems and methods for the treatment of hemoglobinopathies

US Patent 12031132 · Granted Jul 9, 2024

Estimated economic value: $7,129,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crispr-CPF1-related methods, compositions and components for cancer immunotherap2025
Methods for efficient delivery of therapeutic molecules in vitro and in vivo2024
Cas9 fusion molecules, gene editing systems, and methods of use thereof2024
Efficient delivery of therapeutic molecules to cells of the inner ear2024
CRISPR/RNA-guided nuclease systems and methods2024
CRISPR/RNA-guided nuclease systems and methods2024
CRISPR/RNA-guided nuclease systems and methods2024
CRISPR/Cas-related methods and compositions for improving transplantation2024
Systems and methods for the treatment of hemoglobinopathies2023
Systems and methods for the treatment of hemoglobinopathies2023
Systems and methods for the treatment of hemoglobinopathies2023
Optimized CRISPR/cas9 systems and methods for gene editing in stem cells2022